Andrzej Czarnecki,
MD, PhD, DSc
Member, Audit Committee
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd.
Andrzej Czarnecki is a physician and a scientist. He has a distinguished career spanning over many years in medicine, pharmacology, regulation and pharmacovigilance in regulatory authorities and industry, and as a consultant to public bodies e.g. WHO and EU Commission projects and governments of countries on different continents (Denmark, Slovenia, Germany, Kazakhstan, Ukraine, Kyrgyzstan and others).
Dr. Czarnecki has also been active at several universities as Professor of Pharmacoepidemiology and head of PV and Clinical Trials Departments, authoring over 120 research papers. He is a member of several professional societies an elected fellow of the Faculty of Pharmaceutical Medicine and the International Society of Pharmacoepidemiology.
Dr. Czarnecki joined DIA in 1992. He has been a member of Steering Committees: for International Development (1997-99) and of Europe (SCE: 1996-2004), first as a regulator and later as an industry representative. After stepping down from the SCE, Dr. Czarnecki was appointed Editor-in-Chief of DIA Forum by the DIA Board of Directors. He was chair of the DIA 2003 EuroMeeting, and a member of the programme and advisory committees for several subsequent DIA EuroMeetings (2001-2007), workshops, and training courses. In the 1990s Dr. Czarnecki led the DIA expansion into Central/Eastern Europe and championed numerous contacts with regulatory authorities. In recognition of his contributions, he received the DIA ‘Outstanding Services Award’ in 2004. In 2009, Dr. Czarnecki transformed DIA Forum into the Global Forum, which he continued to lead until being elected to the Board in 2013.
Our Leadership
-
Joseph Scheeren,
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
John A. Roberts,
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
Rebecca Vermeulen,
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
Jeffrey S. Payne,
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
Barbara Lopez Kunz,
MS • Global Chief Executive
DIA
-
Andrzej Czarnecki,
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
Angelika Joos,
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
Judith Ng-Cashin,
MD •Director DIA
Chief Scientific Officer
Syneos Health -
Michael Romano,
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
Michael Rosenblatt,
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
Jonathan Sheldon,
PhD •Director DIA
Senior Vice President
QIAGEN -
Kihito Takahashi,
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
Lingshi Tan,
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
Cynthia L. Verst,
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
Joseph Scheeren,
PharmD • Chair, Executive Committee
-
Jeffrey S. Payne,
CPA • Member, Executive Committee -
John A. Roberts,
MBA • Member, Executive Committee -
Rebecca Vermeulen,
RPh • Member, Executive Committee -
Barbara Lopez Kunz,
MS • Member, Executive Committee
-
Michael Romano,
CPA • Chair, Audit Committee -
Andrzej Czarnecki,
MD, PhD, DSc • Member, Audit Committee -
Angelika Joos,
MPharm • Member, Audit Committee -
Joseph Scheeren,
PharmD • Member, Audit Committee -
Cynthia L. Verst,
PharmD • Member, Audit Committee
-
Yoshiaki Uyama,
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
Peter Bachmann,
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
Gerald J. Dal Pan,
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
Petra Dörr,
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
Barbara Lopez Kunz,
MS • Global Chief Executive -
Bayard G. Gardineer,
MS, CPA • Chief Financial Officer -
Timothy Hess • Global Director of IT
-
Thomas Bols • Senior Vice President & Managing Director
DIA EMEA -
Youngshin Lee,
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
Sudip S. Parikh,
PhD • Senior Vice President & Managing Director
DIA Americas -
Akio Uemura,
PhD • Senior Vice President & Managing Director
DIA Japan -
Carol Zhu,
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China
